Presentation TCT 2022 Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertension: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial Presenter: Deepak Bhatt September 18, 2022
Presentation TCT 2022 Endovascular Ultrasound Renal Denervation to Treat Uncontrolled Hypertension: Primary Results of the Randomized, Sham-Controlled RADIANCE II Pivotal Trial Presenter: Ajay Kirtane September 18, 2022
Presentation TCT 2022 Continual Ambulatory Blood Pressure Monitoring System Will Change the Paradigm of Hypertension Care (Aktiia) Presenter: Jay Shah September 17, 2022
Presentation TCT 2022 Novel Devices to Treat Hypertension: What Else Should We Expect in the Near Future? Presenter: Felix Mahfoud September 17, 2022
Presentation TCT 2022 Update on the RADIANCE Clinical Trials Program (Ultra-Sound Renal Denervation) Presenter: Naomi Fisher September 17, 2022
Presentation TCT 2022 Update on the SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation) Presenter: David Kandzari September 17, 2022
Presentation TCT 2022 Novel Approaches to Assess Hypertension Control Outside the Office Presenter: Naomi Fisher September 17, 2022
Presentation TCT 2022 Combination Therapy and Patient Outreach to Improve Adherence to Pharmacotherapies Presenter: Melvin Lobo September 17, 2022
Presentation TCT 2022 TCT 215: Association between Renal Sympathetic Denervation and Arterial Stiffness: the ASORAS Study. Presenter: Victor Zeijen September 17, 2022
Presentation TCT 2022 Dietary and Lifestyle Approaches to Hypertension Management: What’s New and What’s Changed Presenter: Debbie Cohen September 17, 2022
Presentation TCT 2022 TCT 214: Single Ablation Renal Denervation – The RADAR Study Experience with the Metavention iRF System Presenter: Horst Sievert September 17, 2022
Presentation TCT 2022 TCT 212: Twenty-Four Month Results in Patients with Resistant Hypertension After Endovascular Ultrasound Renal Denervation in the RADIANCE-HTN TRIO Trial Presenter: Roland Schmieder September 17, 2022
Presentation TCT 211: Home Blood Pressure Response to Ultrasound Renal Denervation - a Patient-level Pooled Analysis of the RADIANCE-HTN SOLO and TRIO Randomised, Sham-controlled Trials Presenter: Andrew Sharp September 17, 2022
Presentation TCT 2022 TCT 213: Impact of Cardiac Neuromodulation Therapy (CNT) on Systolic Blood Pressure and Pulse Pressure in Hypertensive Patients Indicated for a Pacemaker: Results of a Crossover Study Presenter: Daniel Burkhoff September 17, 2022
Presentation TVT 2022 Association Between Severity Of Pulmonary Hypertension and its Effect on 30-Day Mortality, Readmission, ICU Stay And Cost In Patients Undergoing Transcatheter Aortic Valve Replacement, A Multicenter Study Presenter: Mansoor Ahmad June 09, 2022
Presentation EuroPCR 2022 Blood pressure and MACE reductions after renal denervation: 3-year GSR results Presenter: Felix Mahfoud May 20, 2022
Presentation EuroPCR 2022 Patient-Level Pooled Analysis of Ultrasound RDN in RADIANCE-HTN SOLO and TRIO Presenter: Ajay J. Kirtane, Michel Azizi May 17, 2022
Presentation ARCH 2022 Anesthesia Update: Dealing with High-Risk Pulmonary Hypertension Patients Presenter: Jonathan Zoller April 23, 2022
Presentation ARCH 2022 Current Status and Future of Renal Denervation for Hypertension Presenter: Tim A. Fischell April 23, 2022
Presentation ACC 2022 The Effects Of A Hypotension-avoidance Strategy Versus A Hypertension-avoidance Strategy In Patients Undergoing Noncardiac Surgery Presenter: Maura Marcucci April 04, 2022